Grant: Catalyst Grant: Avian Influenza OneHealth Research
University of Guelph
$148,989.00
Pandemic preparedness: Newcastle disease virus-vectored vaccine against HPAI H5
EF 2024-25
Résumé
Over the past decade, highly pathogenic avian influenza virus strains from Eurasia have increasingly spread to North America, causing severe outbreaks in poultry and posing a threat to humans. A new influenza H5N1 virus reached Eastern Canada in late 2021 via migratory birds. This virus has adapted to local wildlife, becoming endemic in wild birds in North America. It has also been shown to infect various mammals, including ruminants like goats and dairy cows, where it accumulates at high concentration in udder and milk. This broad host range increases the risk of human infection.
As these viruses become more common in farm animals, there is growing support for livestock vaccination, which can improve animal welfare and protect human health by reducing virus spread. Our proposal aims to test a new vaccine using a non-virulent Newcastle disease virus (NDV) to deliver a component of the influenza virus (the H5 gene) to promote antibody development in chickens, ducks, and sheep (as a model for dairy cows). This vaccine can be administered through mucosal routes, like sprays or drinking water, making mass vaccination easier.
We plan to develop three NDV vaccine candidates expressing different versions of the H5 gene. We will first test these candidates for effectiveness in hamsters and chickens. The best candidate will then be tested in chickens and ducks to see if it can protect against H5N1 infection and transmission. Lastly, we will test the vaccine's effectiveness in lactating sheep, specifically focusing on antibody release in milk.
This research will help Canada prepare for H5N1 outbreaks by developing an effective vaccine. It will also provide important data to guide policies on livestock vaccination, potentially reducing virus transmission. The project involves collaboration between the University of Guelph, the University of Toronto, the Canadian Food Inspection Agency, and the Ontario Ministry of Agriculture, Food and Rural Affairs.
Programme
Catalyst Grant: Avian Influenza OneHealth Research
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
507215
Name
Susta Leonardo
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Catalyst Grant: Catalyzing OneHealth Research on Avian Influenza
Projecttitle
Pandemic preparedness: Newcastle disease virus-vectored vaccine against HPAI H5
Programtype2
Operating Grants
Orgnameinp2
University of Guelph
Cihramount2
$148,989
Cihrequipment2
$0
Programname2
Catalyst Grant: Avian Influenza OneHealth Research
Keyworddelim
Avian Orthoavulavirus-1; Chickens; En Mass Vaccine Delivery; Lentogenic; Mucosal Immunity; Newcastle Disease Virus; Pandemic Preparedness Through Livestock Vaccination; Small Ruminants; Transmission Limitation; Waterfowl
Abstract
Over the past decade, highly pathogenic avian influenza virus strains from Eurasia have increasingly spread to North America, causing severe outbreaks in poultry and posing a threat to humans. A new influenza H5N1 virus reached Eastern Canada in late 2021 via migratory birds. This virus has adapted to local wildlife, becoming endemic in wild birds in North America. It has also been shown to infect various mammals, including ruminants like goats and dairy cows, where it accumulates at high concentration in udder and milk. This broad host range increases the risk of human infection.
As these viruses become more common in farm animals, there is growing support for livestock vaccination, which can improve animal welfare and protect human health by reducing virus spread. Our proposal aims to test a new vaccine using a non-virulent Newcastle disease virus (NDV) to deliver a component of the influenza virus (the H5 gene) to promote antibody development in chickens, ducks, and sheep (as a model for dairy cows). This vaccine can be administered through mucosal routes, like sprays or drinking water, making mass vaccination easier.
We plan to develop three NDV vaccine candidates expressing different versions of the H5 gene. We will first test these candidates for effectiveness in hamsters and chickens. The best candidate will then be tested in chickens and ducks to see if it can protect against H5N1 infection and transmission. Lastly, we will test the vaccine's effectiveness in lactating sheep, specifically focusing on antibody release in milk.
This research will help Canada prepare for H5N1 outbreaks by developing an effective vaccine. It will also provide important data to guide policies on livestock vaccination, potentially reducing virus transmission. The project involves collaboration between the University of Guelph, the University of Toronto, the Canadian Food Inspection Agency, and the Ontario Ministry of Agriculture, Food and Rural Affairs.
Competitiondate
202407
Approvedterm2
1 yr 0 mth
Pinamesdelim
Susta, Leonardo
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $148,989~ $0~